|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.05 EUR | +0.58% |
|
-2.44% | -8.12% |
| 07-01 | Delfin deadlocked, Del Vecchio skips meeting as heirs approve 2025 accounts | AN |
| 06-19 | Covivio Maintained Among Deloitte Frances Best Managed Companies |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.55 | 1.83 | 1.8 | 2.4 | 2.05 | |||||
Return on Total Capital | 1.68 | 1.98 | 1.95 | 2.6 | 2.21 | |||||
Return On Equity % | 9.88 | 8.28 | -14.61 | 1.65 | 9.4 | |||||
Return on Common Equity | 10.39 | 6.66 | -16.31 | 0.84 | 8.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 78.97 | 80.44 | 79.72 | 94.5 | 83 | |||||
EBITDA Margin % | 81.04 | 82.44 | 81.85 | 95.62 | 84.63 | |||||
EBITA Margin % | 71.95 | 76.81 | 74.84 | 85.53 | 72.24 | |||||
EBIT Margin % | 71.5 | 76.63 | 74.62 | 85.53 | 71.94 | |||||
Income From Continuing Operations Margin % | 133.86 | 107.45 | -186.63 | 17.63 | 101.2 | |||||
Net Income Margin % | 95.54 | 58.1 | -139.15 | 6.08 | 64.45 | |||||
Net Avail. For Common Margin % | 95.54 | 58.1 | -139.15 | 6.08 | 64.45 | |||||
Normalized Net Income Margin | 3.53 | 23.41 | 70.17 | 26.42 | -2.12 | |||||
Levered Free Cash Flow Margin | -71.17 | 15.69 | -0.06 | 8.55 | -35.47 | |||||
Unlevered Free Cash Flow Margin | -62.41 | 23.73 | 16.88 | 31.9 | -17.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | |||||
Fixed Assets Turnover | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | |||||
Receivables Turnover (Average Receivables) | 2.86 | 2.57 | 2.86 | 3.02 | 3.29 | |||||
Inventory Turnover (Average Inventory) | 0.88 | 0.88 | 0.72 | 0.22 | 0.59 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.04 | 0.89 | 1 | 0.95 | 0.91 | |||||
Quick Ratio | 0.62 | 0.52 | 0.61 | 0.65 | 0.58 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.36 | 0.47 | 0.44 | 0.3 | |||||
Days Sales Outstanding (Average Receivables) | 127.73 | 141.95 | 127.71 | 121.15 | 110.8 | |||||
Days Outstanding Inventory (Average Inventory) | 414.13 | 415.81 | 504.51 | 1.69K | 619.92 | |||||
Average Days Payable Outstanding | 304.11 | 207.09 | 244.53 | 5.25K | 237.1 | |||||
Cash Conversion Cycle (Average Days) | 237.75 | 350.67 | 387.69 | -3.44K | 493.61 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 90.59 | 82.14 | 93.67 | 90.76 | 87.27 | |||||
Total Debt / Total Capital | 47.53 | 45.1 | 48.37 | 47.58 | 46.6 | |||||
LT Debt/Equity | 77.07 | 72.77 | 81.46 | 79.11 | 71.36 | |||||
Long-Term Debt / Total Capital | 40.44 | 39.95 | 42.06 | 41.47 | 38.11 | |||||
Total Liabilities / Total Assets | 51.76 | 49.06 | 52.2 | 51.73 | 50.07 | |||||
EBIT / Interest Expense | 4.22 | 5.13 | 2.51 | 2.27 | 2.43 | |||||
EBITDA / Interest Expense | 4.78 | 5.52 | 2.75 | 2.53 | 2.85 | |||||
(EBITDA - Capex) / Interest Expense | 0.52 | 1.96 | 1.15 | 1.12 | 1.15 | |||||
Total Debt / EBITDA | 15.75 | 13.14 | 13.43 | 10.19 | 11.38 | |||||
Net Debt / EBITDA | 14.39 | 12.62 | 12.35 | 9.25 | 10.14 | |||||
Total Debt / (EBITDA - Capex) | 143.66 | 36.99 | 32.02 | 22.98 | 28.28 | |||||
Net Debt / (EBITDA - Capex) | 131.29 | 35.52 | 29.44 | 20.86 | 25.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.75 | 10.51 | -4.56 | 9.77 | 2.4 | |||||
Gross Profit, 1 Yr. Growth % | 5.83 | 12.57 | -5.42 | 11.17 | 2.89 | |||||
EBITDA, 1 Yr. Growth % | 7.41 | 14.93 | -4.91 | 10.01 | 3.5 | |||||
EBITA, 1 Yr. Growth % | 9.79 | 18.71 | -6.79 | 6.46 | 0.44 | |||||
EBIT, 1 Yr. Growth % | 9.11 | 18.44 | -7.06 | 6.46 | 0.02 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 229.89 | -11.29 | -265.77 | -110.37 | 487.84 | |||||
Net Income, 1 Yr. Growth % | 156.72 | -32.8 | -328.58 | -104.8 | 984.73 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 154.71 | -32.48 | -320.17 | -104.33 | 952.38 | |||||
Normalized Net Income, 1 Yr. Growth % | -80.41 | 633.62 | 186.08 | -63.12 | -111.45 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2 | -0.02 | -11.27 | -1.65 | 0.25 | |||||
Inventory, 1 Yr. Growth % | -14.98 | 24.56 | 16.47 | -15.19 | 53.72 | |||||
Accounts Receivable, 1 Yr. Growth % | 40.69 | -7.45 | -6.31 | 0.59 | -22.22 | |||||
Total Assets, 1 Yr. Growth % | 3.13 | -2.04 | -9.53 | -0.55 | 1.81 | |||||
Common Equity, 1 Yr. Growth % | 7.13 | 2.71 | -15.74 | 3.41 | 4.69 | |||||
Tangible Book Value, 1 Yr. Growth % | 7.6 | 2.69 | -15.96 | 0.8 | 4.9 | |||||
Cash From Operations, 1 Yr. Growth % | 37.54 | 1.37 | 46.86 | -4.36 | -16.41 | |||||
Capital Expenditures, 1 Yr. Growth % | 10.48 | -18.59 | -14.68 | 22.97 | -2.72 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 147.34 | -123.77 | -100.39 | 37.32 | -3.35K | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 217.66 | -140.87 | -31.24 | 22.07 | -171.52 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.17 | 0 | -12 | 6.06 | 7.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -6.49 | 7.59 | 2.7 | 2.35 | 6.02 | |||||
Gross Profit, 2 Yr. CAGR % | -7.74 | 9.15 | 3.19 | 10.94 | 0 | |||||
EBITDA, 2 Yr. CAGR % | -6.97 | 9.89 | 4.35 | 10.43 | -0.14 | |||||
EBITA, 2 Yr. CAGR % | -9.02 | 13.81 | 5.07 | 8.14 | -4.05 | |||||
EBIT, 2 Yr. CAGR % | -9.3 | 13.68 | 4.92 | 8.14 | -4.24 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.27 | 71.07 | 21.26 | -58.54 | -21.93 | |||||
Net Income, 2 Yr. CAGR % | 11.19 | 31.35 | 23.94 | -66.88 | -27.84 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 6.31 | 31.14 | 22.3 | -69.13 | -32.5 | |||||
Normalized Net Income, 2 Yr. CAGR % | -63.72 | 19.9 | 358.12 | 8.74 | -82.58 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.86 | 0.99 | -5.81 | -6.58 | -0.7 | |||||
Inventory, 2 Yr. CAGR % | -4.53 | 2.91 | 20.45 | -0.61 | 14.18 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.57 | 14.11 | -6.88 | -2.92 | -11.55 | |||||
Total Assets, 2 Yr. CAGR % | 4.78 | 0.51 | -5.86 | -5.14 | 0.62 | |||||
Common Equity, 2 Yr. CAGR % | 5.26 | 4.9 | -6.97 | -6.65 | 4.05 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.57 | 5.12 | -7.1 | -7.96 | 2.83 | |||||
Cash From Operations, 2 Yr. CAGR % | -5.64 | 18.08 | 22.01 | 18.52 | -10.59 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.71 | -5.16 | -16.66 | 2.43 | 9.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 225.32 | -22.38 | -96.98 | -23.73 | 141.6 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 318.25 | 15.53 | -47.33 | 19.43 | -18.16 | |||||
Dividend Per Share, 2 Yr. CAGR % | -11.61 | 2.06 | -6.19 | -3.39 | 6.6 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -8.48 | -1.14 | 3.38 | 5 | 2.37 | |||||
Gross Profit, 3 Yr. CAGR % | -4.42 | -1.41 | 4.06 | 11.48 | 3.45 | |||||
EBITDA, 3 Yr. CAGR % | -3.71 | -0.91 | 4.59 | 11.77 | 3.39 | |||||
EBITA, 3 Yr. CAGR % | -5.24 | -0.78 | 6.4 | 11.47 | 0.38 | |||||
EBIT, 3 Yr. CAGR % | -5.43 | -0.86 | 6.3 | 11.47 | 0.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 4.21 | -3.1 | 69.28 | -46.58 | 0.34 | |||||
Net Income, 3 Yr. CAGR % | 7.21 | -5.99 | 57.99 | -58.07 | 5.97 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.81 | -8.62 | 56.18 | -59.84 | 0.1 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.31 | -1.16 | 60.21 | 105.48 | -54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.71 | 3.21 | -3.27 | -4.44 | -4.36 | |||||
Inventory, 3 Yr. CAGR % | 30.3 | 4.32 | 7.24 | 7.15 | 14.94 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.95 | -2.92 | 6.85 | -4.45 | -9.83 | |||||
Total Assets, 3 Yr. CAGR % | 5.01 | 2.46 | -2.95 | -4.12 | -2.88 | |||||
Common Equity, 3 Yr. CAGR % | 6.73 | 4.4 | -2.49 | -3.63 | -3.02 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.04 | 4.6 | -2.44 | -4.54 | -3.86 | |||||
Cash From Operations, 3 Yr. CAGR % | -8 | -3.36 | 26.98 | 12.5 | 5.5 | |||||
Capital Expenditures, 3 Yr. CAGR % | -11.06 | -5.56 | -8.45 | -5.12 | 0.69 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.21 | 37.12 | -86.76 | -48.62 | 35.23 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.77 | 94.44 | -3.23 | -16.82 | -7.85 | |||||
Dividend Per Share, 3 Yr. CAGR % | -6.58 | -7.9 | -2.86 | -2.27 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.03 | 1.37 | -4.16 | 0.25 | 4.43 | |||||
Gross Profit, 5 Yr. CAGR % | 0.07 | 1.51 | -1.45 | 3.35 | 5.69 | |||||
EBITDA, 5 Yr. CAGR % | 0.94 | 2.17 | -1 | 3.41 | 5.87 | |||||
EBITA, 5 Yr. CAGR % | -1.21 | 0.99 | -1.36 | 2.64 | 5.5 | |||||
EBIT, 5 Yr. CAGR % | -1.33 | 0.94 | -1.42 | 2.64 | 5.41 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.87 | -3.23 | 10.72 | -31 | 24.21 | |||||
Net Income, 5 Yr. CAGR % | 3.36 | -7.45 | 13.61 | -38.06 | 15.48 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -3.39 | -11.83 | 9.56 | -40.73 | 11.66 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.74 | 17.23 | 88.54 | 2.69 | -32.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.74 | 5.68 | 0.37 | -0.82 | -2.25 | |||||
Inventory, 5 Yr. CAGR % | 43.63 | 43.6 | 26.27 | 2.32 | 9.96 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.44 | 4.3 | 0.61 | -2.92 | -0.93 | |||||
Total Assets, 5 Yr. CAGR % | 7.69 | 4.94 | 0.52 | -0.66 | -1.54 | |||||
Common Equity, 5 Yr. CAGR % | 11.64 | 8.21 | 1.02 | -0.17 | 0.07 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.42 | 7.99 | 1.14 | -0.62 | -0.37 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.76 | -1.11 | 3 | 4.86 | 10.36 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.77 | -12.61 | -13.34 | -2.44 | -1.7 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 95.28 | -26.87 | -73.57 | 8.03 | 7.89 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 28.89 | -18.01 | -15.48 | 59.59 | 0.62 | |||||
Dividend Per Share, 5 Yr. CAGR % | -3.15 | -3.58 | -6.43 | -6.12 | 0.82 |
- Stock Market
- Stocks
- COV Stock
- Financials Covivio
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















